← back to search

Chenxi He

Xihua University · CN
Area of research
Molecular Biology · Materials Chemistry
Research interest
Research interests include Catalytic Processes in Materials Science, RNA modifications and cancer, Catalysis and Oxidation Reactions, and Cancer-related gene regulation.
h-index
30
citations
3,731
works
103
NIH funding
primary concept
email

Recent publications

Mutation of CHD7 impairs the output of neuroepithelium transition that is reversed by the inhibition of EZH2
Molecular Psychiatry 2025cited by 2position: middledoi
Radiotherapy-sensitized cancer immunotherapy via cGAS-STING immune pathway by activatable nanocascade reaction
Journal of Nanobiotechnology 2024cited by 31position: middledoi
Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses
Nature Cell Biology 2022cited by 201position: middledoi
Dynamic control of chromatin-associated m6A methylation regulates nascent RNA synthesis
Molecular Cell 2022cited by 147position: middledoi
Activation of Pancreatic Acinar FXR Protects against Pancreatitis via Osgin1-Mediated Restoration of Efficient Autophagy
Research 2022cited by 33position: middledoi
Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers
Cell Reports 2022cited by 29position: middledoi
METTL3 regulates heterochromatin in mouse embryonic stem cells
Nature 2021cited by 390position: middledoi
Core transcription regulatory circuitry orchestrates corneal epithelial homeostasis
Nature Communications 2021cited by 61position: middledoi
Qki activates Srebp2-mediated cholesterol biosynthesis for maintenance of eye lens transparency
Nature Communications 2021cited by 48position: middledoi
Evaluation of the Efficacy and Prognosis of MRI Combined with miR-134 in Neo-adjuvant Chemotherapy Combined with Breast-conserving Surgery
Tobacco Regulatory Science 2021cited by 0position: middledoi
Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection
Cell Reports 2020cited by 163position: middledoi
Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα–mediated lipid metabolism
Journal of Clinical Investigation 2020cited by 97position: middledoi
HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer
Oncogene 2019cited by 47position: middledoi
Zc3h13 Regulates Nuclear RNA m6A Methylation and Mouse Embryonic Stem Cell Self-Renewal
Molecular Cell 2018cited by 981position: middledoi
Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex
Cell 2016cited by 188position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Fei Lan · Shanghai Medical College of Fudan University6 papers (2016–2025)Hongjie Shen · Central South University4 papers (2016–2022)Yujiang Geno Shi · Shanghai Medical College of Fudan University4 papers (2016–2022)Yang Shi · Wuhan University4 papers (2016–2022)Feizhen Wu · Fudan University3 papers (2016–2022)Fei Lan · Beijing Institute of Technology3 papers (2021–2022)Wenqi Xu · Fudan University3 papers (2016–2022)Pengyuan Yang · Shanghai Medical College of Fudan University2 papers (2016–2018) · 2 papers (2020–2021)Honghui Ma · Hunan University2 papers (2018–2021)Xin Zhou · Fudan University2 papers (2020–2021)Jian Hu · Obstetrics and Gynecology Hospital of Fudan University2 papers (2020–2021)Yunfei Wang · Southern University of Science and Technology2 papers (2020–2021)Yiwen Chen · Wannan Medical College2 papers (2020–2021)Jing Wen · Southwest University2 papers (2018–2021)Ruitu Lv · Fudan University2 papers (2018–2019)Bowen Rong · Fudan University2 papers (2016–2021)Li Tan · Shanghai Medical College of Fudan University2 papers (2018–2021)Hong Ouyang · Guangxi Normal University1 papers (2021–2021)Sufen Han · Shanghai University of Traditional Chinese Medicine1 papers (2021–2021)